A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis

NCT07080125 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Lung Diseases
Systemic Sclerosis Associated Interstitial Lung Disease

Interventions

DRUG: Ofev®

Sponsor

Boehringer Ingelheim